HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.

Abstract
Fatty acid synthase (FAS) is a major lipogenic enzyme catalyzing the synthesis of long-chain saturated fatty acids. Most breast cancers require lipogenesis for growth. Here, we demonstrated the effects of theanaphthoquinone (TNQ), a member of the thearubigins generated by the oxidation of theaflavin (TF-1), on the expression of FAS in human breast cancer cells. TNQ was found to suppress the EGF-induced expression of FAS mRNA and FAS protein in MDA-MB-231 cells. Expression of FAS has previously been shown to be regulated by the SREBP family of transcription factors. In this study, we demonstrated that the EGF-induced nuclear translocation of SREBP-1 was blocked by TNQ. Moreover, TNQ also modulated EGF-induced ERK1/2 and Akt phosphorylation. Treatment of MDA-MB-231 cells with PI 3-kinase inhibitors, LY294002 and Wortmannin, inhibited the EGF-induced expression of FAS and nuclear translocation of SREBP-1. Treatment with TNQ inhibited EGF-induced EGFR/ErbB-2 phosphorylation and dimerization. Furthermore, treatment with kinase inhibitors of EGFR and ErbB-2 suggested that EGFR/ErbB-2 activation was involved in EGF-induced FAS expression. In constitutive FAS expression, TNQ inhibited FAS expression and Akt autophosphorylation in BT-474 cells. The PI 3-kinase inhibitors and tyrosine kinase inhibitors of EGFR and ErbB-2 also reduced constitutive FAS expression. In addition, pharmacological blockade of FAS by TNQ decreased cell viability and induced cell death in BT-474 cells. In summary, our findings suggest that TNQ modulates FAS expression by the regulation of EGFR/ErbB-2 pathways and induces cell death in breast cancer cells.
AuthorsMeng-Shih Weng, Chi-Tang Ho, Yuan-Soon Ho, Jen-Kun Lin
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 218 Issue 2 Pg. 107-18 (Jan 15 2007) ISSN: 0041-008X [Print] United States
PMID17182072 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Naphthoquinones
  • Sterol Regulatory Element Binding Protein 1
  • fas Receptor
  • theanaphthoquinone
  • Tyrosine
  • Epidermal Growth Factor
  • Fatty Acid Synthases
  • Phosphatidylinositol 3-Kinases
  • ErbB Receptors
  • Oncogene Protein v-akt
Topics
  • Blotting, Western
  • Breast Neoplasms (metabolism, pathology)
  • Cell Death (drug effects)
  • Cell Line, Tumor
  • Cell Nucleus (drug effects, ultrastructure)
  • Cell Survival (drug effects)
  • Down-Regulation (physiology)
  • Epidermal Growth Factor (pharmacology)
  • ErbB Receptors (genetics)
  • Fatty Acid Synthases (antagonists & inhibitors)
  • Female
  • Flow Cytometry
  • Genes, erbB-2 (genetics)
  • Humans
  • Immunoprecipitation
  • Naphthoquinones (pharmacology)
  • Oncogene Protein v-akt (metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphorylation
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction (drug effects)
  • Sterol Regulatory Element Binding Protein 1 (genetics, metabolism)
  • Stimulation, Chemical
  • Translocation, Genetic
  • Tyrosine (metabolism)
  • fas Receptor (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: